Testing effectiveness (Phase 2)Ended earlyNCT02054104
What this trial is testing
Adjuvant Tumor Lysate Vaccine and Iscomatrix With or Without Metronomic Oral Cyclophosphamide and Celecoxib in Patients With Malignancies Involving Lungs, Esophagus, Pleura, or Mediastinum
Who this might be right for
Thoracic SarcomasThorasic CancersCancers of Non-thoracic Origin With Metastases to the Lungs or Pleura+2 more
National Cancer Institute (NCI) 21